Amarin Corp Plc (AMRN)

[KCSVEN]

Expected by me all along, but expected after FDA approval, I would assume they think approval is in the bag(safe assumption)? Otherwise they don't need the money.

5% or so dilution and depending on final price will be the new "number they can't get over" for the stock price for awhile.

In addition the timing gives them strength in BO negotiations after approval also, pay now or we have plenty of ammo for GIA, not like whatever money is left is not paid for in a BO so has no effect on ST BO price.

$400 million seems like overkill unless they are using half that to invest in higher capacity and it does say that might be part of it

" (2) to increase commercial supply of Vascepa from third-party drug product suppliers"

Not shocked as totally expected a raise, a little surprised by the timing and size.

Stock will likely not recover above 20 until after approval, too bad there but is what it is.